Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents
暂无分享,去创建一个
A. Atz | M. Cohen-Wolkowiez | D. Gonzalez | Elizabeth H. Payne | P. Mourani | R. Yogev | C. Melloni | K. Watt | C. Hornik | J. Sullivan | A. Al-Uzri | B. Harper | M. Adu-Darko | Susan Lin | Casey E Gelber | D. Speicher
[1] S. Goldstein,et al. Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery , 2019, Clinical Pharmacokinetics.
[2] S. Goldstein,et al. Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review , 2016, Journal of cardiovascular pharmacology.
[3] I. Mahmood,et al. Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical Models , 2016, The AAPS Journal.
[4] P. Cogo,et al. Vasoactive Drugs and Hemodynamic Monitoring in Pediatric Cardiac Intensive Care , 2016, World journal for pediatric & congenital heart surgery.
[5] S. Goldstein,et al. Retrospective Evaluation of Milrinone Pharmacokinetics in Children With Kidney Injury , 2015, Therapeutic drug monitoring.
[6] Angela S Czaja,et al. Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research. , 2015, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
[7] G. Rücker,et al. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. , 2015, The Cochrane database of systematic reviews.
[8] Nick Holford,et al. A pharmacokinetic standard for babies and adults. , 2013, Journal of pharmaceutical sciences.
[9] D. Lenihan,et al. Elevation of Plasma Milrinone Concentrations in Stage D Heart Failure Associated With Renal Dysfunction , 2013, Journal of cardiovascular pharmacology and therapeutics.
[10] P. McNamara,et al. Pharmacology of Milrinone in Neonates With Persistent Pulmonary Hypertension of the Newborn and Suboptimal Response to Inhaled Nitric Oxide* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[11] Andrew C. Hooker,et al. Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models , 2011, The AAPS Journal.
[12] C. Parshuram,et al. Use of milrinone in critically ill children. , 2010, The Canadian journal of hospital pharmacy.
[13] G. Schwartz,et al. Measurement and estimation of GFR in children and adolescents. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[14] M. Coulthard,et al. Human renal function maturation: a quantitative description using weight and postmenstrual age , 2009, Pediatric Nephrology.
[15] N. Gretz,et al. Bias and precision of estimated glomerular filtration rate in children , 2007, Pediatric Nephrology.
[16] G. Paradis,et al. Validation of child serum creatinine-based prediction equations for glomerular filtration rate , 2007, Pediatric Nephrology.
[17] A. McLachlan,et al. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants , 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[18] S. Nicolson,et al. Population Pharmacokinetics of Milrinone in Neonates with Hypoplastic Left Heart Syndrome Undergoing Stage I Reconstruction , 2006, Anesthesia and analgesia.
[19] E. Niclas Jonsson,et al. PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM , 2005, Comput. Methods Programs Biomed..
[20] S. Hellerstein,et al. Comparison of two formulae for estimation of glomerular filtration rate in children , 2004, Pediatric Nephrology.
[21] D. Nelson,et al. A Population Pharmacokinetic Analysis of Milrinone in Pediatric Patients After Cardiac Surgery , 2004, Journal of Pharmacokinetics and Pharmacodynamics.
[22] I. Piña,et al. Pharmacodynamic effects of milrinone with and without a bolus loading infusion. , 2001, American heart journal.
[23] F. Lokiec,et al. Pharmacokinetics of Oral Acyclovir in Neonates and in Infants: a Population Analysis , 2001, Antimicrobial Agents and Chemotherapy.
[24] M. Yano,et al. Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum. , 2000, American journal of physiology. Heart and circulatory physiology.
[25] K. Okeie,et al. Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration , 2000, Intensive Care Medicine.
[26] K. Kanter,et al. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. , 1999, Anesthesiology.
[27] S. Lawless,et al. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. , 1998, The Journal of pediatrics.
[28] Glyn Williams,et al. Pharmacokinetics and Side Effects of Milrinone in Infants and Children After Open Heart Surgery , 1998, Anesthesia and analgesia.
[29] M. Hess,et al. Milrinone: basic and clinical pharmacology and acute and chronic management. , 1996, The American journal of the medical sciences.
[30] M. Kikura,et al. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. , 1994 .
[31] J. Peacock,et al. Disposition of milrinone in patients after cardiac surgery. , 1994, British journal of anaesthesia.
[32] H. Nawrath,et al. Pharmacology of bipyridine phosphodiesterase III inhibitors. , 1991, European journal of anaesthesiology. Supplement.
[33] R. A. Young,et al. Milrinone , 1988, Drugs.
[34] R. Stroshane,et al. Oral and intravenous pharmacokinetics of milrinone in human volunteers. , 1984, Journal of pharmaceutical sciences.
[35] Jos H. Beijnen,et al. Piraña and PCluster: A modeling environment and cluster infrastructure for NONMEM , 2011, Comput. Methods Programs Biomed..
[36] T. Mock,et al. Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. , 2006, Journal of the American Society of Nephrology : JASN.
[37] P. Pentikäinen,et al. Pharmacokinetics and Pharmacodynamics of Intravenous Inotropic Agents , 2004, Clinical pharmacokinetics.
[38] H. Liedholm,et al. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment , 2004, European Journal of Clinical Pharmacology.
[39] E N Jonsson,et al. Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. , 1999, Computer methods and programs in biomedicine.